Efficacy and safety of atezolizumab (atezo) and bevacizumab (bev) in a phase Ib study of microsatellite instability (MSI)-high metastatic colorectal cancer (mCRC).
暂无分享,去创建一个
J. Bendell | H. Hochster | K. Iizuka | S. Eckhardt | Wei Zhang | J. Cleary | Xian He | P. Foster | G. Hernandez